United States Food and Drug Administration
"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
| Descriptor ID |
D014486
|
| MeSH Number(s) |
I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".
This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 3 | 4 |
| 2009 | 0 | 4 | 4 |
| 2010 | 2 | 11 | 13 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 8 | 8 |
| 2013 | 2 | 2 | 4 |
| 2014 | 1 | 4 | 5 |
| 2015 | 0 | 4 | 4 |
| 2016 | 2 | 5 | 7 |
| 2017 | 1 | 7 | 8 |
| 2018 | 1 | 7 | 8 |
| 2019 | 1 | 7 | 8 |
| 2020 | 2 | 5 | 7 |
| 2021 | 2 | 6 | 8 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 4 | 5 |
| 2025 | 0 | 4 | 4 |
| 2026 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.
-
Generic and Biosimilar Prescribing in Children and Adolescents: Technical Report. Pediatrics. 2026 Jun 01; 157(6).
-
Generic and Biosimilar Prescribing in Children and Adolescents: Policy Statement. Pediatrics. 2026 Jun 01; 157(6).
-
Improving the Infrastructure for Pediatric Medical Device Trials at Children's Hospitals. Pediatrics. 2025 Apr 01; 155(4).
-
Patterns of immunotherapy utilization for non-small cell lung cancer in Texas pre- and post-regulatory approval. Clin Transl Oncol. 2024 Aug; 26(8):1908-1920.
-
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 12; 177:120-142.
-
Results of the United States Food and Drug Administration Clinical Trial of the CustomFlex Artificial Iris. Ophthalmology. 2022 06; 129(6):614-625.
-
Level of evidence for FDA drug approvals in pivotal clinical trials of hematological malignancies. Leuk Lymphoma. 2021 06; 62(6):1522-1524.
-
The Best Pharmaceuticals for Children Act and Pediatric Research Equity Act reach the age of majority-An oncology perspective. Pediatr Blood Cancer. 2021 03; 68(3):e28871.
-
Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here? J Allergy Clin Immunol. 2020 04; 145(4):1153-1156.
-
FDA approval of GLP-1 receptor agonist (liraglutide) for use in children. Lancet Child Adolesc Health. 2019 09; 3(9):595-597.